BioSpace News Archive

Outpatient Clinics Market – Current Scenario with Future Forecast by 2025

An outpatient clinic or a department is one where patients can be treated for their illnesses without having the need to stay at the medical organization conventional outpatient clinics have provided treatment options for common ailments or medical issues that have a swift diagnosis and cure.

June 10, 2020
·
4 min read
Anti-Obesity Prescription Drugs Market: Emergence of Novel Innovations to Offer Rich Growth Opportunity

The global anti-obesity prescription drugs market is expected to see promising growth in forthcoming year, as reported by Transparency Market Research.

June 10, 2020
·
4 min read
Genome Engineering Market: Investment by Pharmaceutical Companies for Developing New Treatments Boost Market Growth

Transparency Market Research has published a new report titled, ‘Genome engineering Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

June 10, 2020
·
5 min read
Rare Hematology Market: Rise in Awareness among Patients Regarding Blood-Related Disease Stokes the Market Growth

The top six rare hematology market players are Bayer Healthcare, CSL Behiring LLC, Novo Nordisk A/S, Alexion Pharmaceuticals, PRA Health Sciences, and Shire plc, who are trying to enhance the scrutinizing process.

June 10, 2020
·
3 min read
Rheumatology Therapeutics Market: DMARDs Account for Maximum Share

The global rheumatology therapeutics market is highly competitive and consolidated due to presence of strong players, finds Transparency Market Research.

June 10, 2020
·
4 min read
Business

Biohaven Appoints Bob Hugin to its Board of Directors

Former Chief Executive Officer and Executive Chairman of Celgene Corporation brings deep leadership experience to Biohaven Board

June 10, 2020
·
6 min read
Genetown

New Results From Landmark NURTURE Study Show That Pre-Symptomatic SMA Patients Treated With SPINRAZA® (nusinersen) Continue to Demonstrate Sustained Benefit From Treatment

After up to 4.8 years of continuous treatment with SPINRAZA, 100 percent of children treated pre-symptomatically were alive, and none require permanent ventilation

June 10, 2020
·
9 min read
Business

Verrica Pharmaceuticals Appoints Diem Nguyen, Ph.D., M.B.A., to its Board of Directors

Global biopharmaceutical industry veteran brings significant commercial expertise and business acumen to help advance the Company’s medical dermatology portfolio

June 10, 2020
·
5 min read
BioCapital

Priority Health Selects The Inovalon ONE® PlatformLeading Health Plan Transitions Initiatives to Inovalon’s Integrated Platform

Inovalon announced a multi-year engagement with Priority Health, a leading Michigan health plan with more than one million members, to provide a configuration of the Inovalon ONE® Platform in support of superior member insights and economic performance for its commercial and Medicare Advantage memberships.

June 10, 2020
·
4 min read
Drug Development

Catalyst Biosciences Completes MarzAA Pharmacokinetic & Pharmacodynamic StudyResults support subcutaneous dosing regimen of the Phase 3 Registrational trial

Catalyst Biosciences, Inc. (NASDAQ: CBIO), a biopharmaceutical company developing novel subcutaneous (SQ) therapies for hemophilia and other bleeding disorders, today announced completion of its Phase 1 MAA-102 study for Marzeptacog alfa (activated) (MarzAA). The results support the use of SQ MarzAA to treat episodic bleeding. The company is on track to enroll the first patient in its Phase 3 registration trial evaluating the effic

June 10, 2020
·
4 min read